CIK: 0001587114 · Show all filings
Period: Q2 2017 (← Previous) (Next →)
Filing Date: Aug 14, 2017
Total Value ($000): $563,229 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ALEXION PHARMACEUTICALS, INC | 569,500 | $78,215 | 13.9% | — | — | Call | 015351909 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 3,753,635 | $70,869 | 12.6% | $10.60 | +37.1% | COM | 46333X108 |
| — | ASSEMBLY BIOSCIENCES INC | 2,943,164 | $60,776 | 10.8% | $8.38 | — | COM | 045396108 |
| — | FIBROGEN INC | 1,585,457 | $51,210 | 9.1% | $32.10 | — | COM | 31572Q808 |
| GLPG | GALAPAGOS NV SPON ADR | 578,505 | $44,267 | 7.9% | $58.59 | — | SPONSORED ADR | 36315X101 |
| ASND | ASCENDIS PHARMA A S | 1,482,600 | $41,157 | 7.3% | $22.80 | — | SPONSORED ADR | 04351P101 |
| — | GILEAD SCIENCES INC | 500,000 | $38,045 | 6.8% | — | — | Call | 375558903 |
| SGMO | SANGAMO BIOSCIENCES INC | 2,568,119 | $22,599 | 4.0% | $6.42 | 0.0% | COM | 800677106 |
| KURA | KURA ONCOLOGY INC COM | 2,033,622 | $18,913 | 3.4% | $10.12 | -10.1% | COM | 50127T109 |
| — | TOCAGEN INC | 1,502,373 | $18,074 | 3.2% | $12.03 | — | COM | 888846102 |
| CTMX | CYTOMX THERAPEUTICS INC | 794,969 | $12,322 | 2.2% | $13.16 | +14.5% | COM | 23284F105 |
| EDIT | EDITAS MEDICINE INC COM | 717,107 | $12,033 | 2.1% | $18.02 | 0.0% | COM | 28106W103 |
| — | CASCADIAN THERAPEUTICS INC | 3,000,000 | $11,145 | 2.0% | $4.14 | — | COM | 14740B606 |
| CRVS | CORVUS PHARMACEUTICALS INC | 805,000 | $9,741 | 1.7% | $10.68 | 0.0% | COM | 221015100 |
| — | VERTEX PHARMACEUTICALS INC | 60,000 | $9,109 | 1.6% | — | — | Call | 92532F900 |
| FATE | FATE THERAPEUTICS INC | 2,537,026 | $8,220 | 1.5% | $3.66 | +4.7% | COM | 31189P102 |
| — | ATYR PHARMA INC | 2,292,659 | $7,795 | 1.4% | $2.92 | — | COM | 002120103 |
| — | OVASCIENCE INC | 3,512,332 | $5,479 | 1.0% | $1.87 | — | COM | 69014Q101 |
| ACRS | ACLARIS THERAPEUTICS INC | 185,472 | $5,030 | 0.9% | $26.78 | +1.5% | COM | 00461U105 |
| — | KINDRED BIOSCIENCES INC | 544,880 | $4,686 | 0.8% | $7.10 | — | COM | 494577109 |
| — | TETRAPHASE PHARMACEUTICALS INC | 633,400 | $4,516 | 0.8% | $7.13 | — | COM | 88165N105 |
| — | EDITAS MEDICINE INC COM | 255,000 | $4,315 | 0.8% | — | — | Call | 28106W903 |
| — | REGULUS THERAPEUTICS INC | 3,709,144 | $3,656 | 0.6% | $1.26 | — | COM | 75915K101 |
| — | ACHILLION PHARMACEUTICALS INC | 742,835 | $3,410 | 0.6% | $4.59 | — | COM | 00448Q201 |
| — | NABRIVA THERAPEUTICS | 264,773 | $2,775 | 0.5% | $10.48 | — | COM | G63637105 |
| — | DICERNA PHARMACEUTICALS INC | 767,992 | $2,435 | 0.4% | $3.28 | — | COM | 253031108 |
| — | ADVERUM BIOTECHNOLOGIES INC | 874,447 | $2,186 | 0.4% | $4.11 | — | COM | 00773U108 |
| — | MINERVA NEUROSCIENCES INC | 223,802 | $1,981 | 0.4% | $8.85 | — | COM | 603380106 |
| — | BIOHAVEN PHARMACEUTICAL HLDG CO LTD | 70,000 | $1,750 | 0.3% | $25.00 | — | COM | G11196105 |
| AGIO | AGIOS PHARMACEUTICALS INC | 23,300 | $1,199 | 0.2% | $43.55 | +17.4% | COM | 00847X104 |
| — | CHEMOCENTRYX INC | 118,000 | $1,104 | 0.2% | $7.28 | — | COM | 16383L106 |
| BMY | BRISTOL MYERS SQUIBB CO | 17,060 | $951 | 0.2% | $39.73 | +0.4% | COM | 110122108 |
| — | CLOVIS ONCOLOGY INC | 10,000 | $936 | 0.2% | $93.60 | — | COM | 189464100 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 10,425 | $831 | 0.1% | $63.91 | 0.0% | COM | 02043Q107 |
| — | SEATTLE GENETICS INC | 15,000 | $776 | 0.1% | $51.73 | — | COM | 812578102 |
| — | ARATANA THERAPEUTICS INC | 100,000 | $723 | 0.1% | $7.23 | — | COM | 03874P101 |